Highlights from the ADVENT educational symposium at EADV 2024 discussing the current understanding of the science and treatment landscape in bullous pemphigoid (BP).
ADVENT hosted an engaging educational symposium at EADV 2024 in Amsterdam, where experts, Joost Meijer, Enno Schmidt, and Donna Aline Culton discussed the heterogeneous clinical presentation, disease burden and diagnosis of BP, and its complex pathophysiology involving autoimmunity and type 2 inflammation. The symposium provided a deep dive into unmet needs and treatment challenges faced by these patients.